Protective Effects of GalNac-Modified Red Blood Cell-Derived Extracellular Vesicles Against Liver Diseases.

Int J Nanomedicine · 2025 · PMC12277184 · PMID 40692538

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP =0.24not close (p > 0.1)

Furthermore, miR-155 expression in the Kupffer cells was also lower in the RBC-EVs/GalNac-miR-155-ASO group compared to that in the GalNac-miR-155-ASO group, although this difference did not reach statistical significance ( P =0.24, Figure S2A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.